Panel SA: Healthcare product market fears fall in investment

At a time when the health products market celebrates the advance of elective surgeries in Brazil, which were suspended in the worst period of the pandemic, there is a fear of a slowdown in foreign investments in technologies for the sector this year.

The problem is the high interest rate, especially in the United States, which reduces risky investments in developing countries, according to José Márcio Gomes, executive director of Abiis (Brazilian Alliance for the Innovative Health Industry).

The entity brings together the market for devices used in diagnostics and treatments, such as prostheses, ventilators and medical instruments.

“To have state-of-the-art technology here in Brazil, you have to invest a lot, and it’s an investment that is not always safe because, after having the technology, it depends on incorporating it into the SUS and ANS [Agência Nacional de Saúde Suplementar]. We are concerned that this will slightly undermine the attraction of new technologies to the country, which come from abroad”, he says.

Joana Cunha with Andressa Motter and Ana Paula Branco ​